
Ad hoc announcement pursuant to Art. 53 LR
Baar (Switzerland), 15 January 2026
Based on preliminary unaudited figures, Ascom reports for fiscal year 2025 net revenue of CHF 292.1 million, which is an increase of around 3.8% at constant currencies, and an EBITDA margin of around 11.5% to 12.0%.
Ascom generated net revenue of CHF 292.1 million for fiscal year 2025 (2024: CHF 286.7 million), which reflects an increase of around 3.8% at constant currencies. At actual currencies, the generated revenue represents an increase of 1.9% compared to the previous year, based on preliminary unaudited figures.
Revenue development in constant currencies showed an increase in all three regions. The best performance was achieved in the Region USA & Canada, with a revenue growth of 7.3%. The performance of this region was supported by one very large order, delivered in December, which contributed to growth and profitability. Region South grew by 4.5%, especially in Germany, Italy, and Central and Eastern Europe. Region North increased the net revenue by 1.5%, compared to 2024, driven by the key markets Norway and Sweden.
Incoming orders amounted to CHF 311.1 million (2024: CHF 307.4 million), representing an increase of 3.2% at constant currencies and of 1.2% at actual currencies. The order backlog stood at CHF 310.7 million as of year-end 2025 (31.12.2024: CHF 301.5 million).
Ascom expects to achieve for fiscal year 2025 an EBITDA margin of around 11.5% to 12.0% (2024: 7.4%). This increase is mainly explained by the increased revenue, the continued operational improvements, as well as the above-mentioned order in the USA.
In line with the higher EBITDA margin, the 2025 Group profit is expected to increase significantly to a low double-digit million amount in CHF (2024: CHF 3.7 million).
Ascom continues to have a solid balance sheet with a net cash position of CHF 29.6 million as of year-end 2025 (31.12.2024: CHF 18.6 million) and an equity ratio of around 40%.
Annual Media Conference 2026
The full details of the financial statements and the 2025 Annual Report, including the dividend proposal and 2026 guidance, will be published on 9 March 2026.
Attachment
随机文章
热门文章

V1.0重磅发布!四维天穹绘构低空天路
Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcar
“兴火·燎原”总冠军诞生,云宏信息《金融高算力轻量云平台》登顶
泳池过滤器怎么选?揭开Waternics水武仕珍珠岩过滤器的“硬核密码”!
Graco推出QUANTM电动双隔膜泵系列的改进产品
2025上海CMEF:鱼跃以“AI+医疗”开启健康管理新纪元
再获殊荣!itc分布式综合管理平台荣获2024年度“分布式处理十大品牌”
北京爱育华医院耳鼻喉头颈外科高品质服务升级
交个朋友严选背后:为何是蛰伏三年的酃酃酒